Now showing items 1-2 of 2

    • Predictors of histological disease progression in untreated, localized prostate cancer. 

      Venkitaraman, R; Norman, A; Woode-Amissah, R; Fisher, C; Dearnaley, D; Horwich, A; Huddart, R; Khoo, V; Thompson, A; Parker, C (2007-09)
      Active surveillance for early prostate cancer is a policy of close monitoring with radical treatment targeted at cases with evidence of disease progression. There is no consensus on the need for or optimum timing of repeat ...
    • Prostate-specific antigen velocity in untreated, localized prostate cancer. 

      Venkitaraman, R; Norman, A; Woode-Amissah, R; Dearnaley, D; Horwich, A; Huddart, R; Parker, C (2008-01)
      <h4>Objective</h4>To report the results of a prospective study of active surveillance of untreated prostate cancer, with a focus on baseline predictors of prostate-specific antigen (PSA) velocity, as PSA velocity before ...